SYRE: Spyre Therapeutics, Inc. Stock

by  •  • Comments Off on SYRE: Spyre Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 998.77
Enterprise Value ($M) 1,106.09
Book Value ($M) 482.61
Book Value / Share 5.42
Price / Book 2.07
NCAV ($M) 482.60
NCAV / Share 8.01
Price / NCAV 2.07

Profitability (mra)
Return on Invested Capital (ROIC) -0.43
Return on Assets (ROA) -0.43
Return on Equity (ROE) -1.37

Liquidity (mrq)
Quick Ratio 8.06
Current Ratio 8.06

Balance Sheet (mrq) ($M)
Current Assets 569.77
Assets 569.78
Liabilities 87.17
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -208.57
Net Income -208.02
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -157.41
Cash from Investing -353.29
Cash from Financing 410.91

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-01 13G Tang Capital Management Llc 5.30
02-14 13G/A Rtw Investments, Lp 6.20 62.22
02-14 13G/A Venrock Healthcare Capital Partners III, L.P. 4.60 0.00
02-14 13G/A Perceptive Advisors Llc 4.40 -10.37
11-14 13G/A Avoro Capital Advisors LLC 1.70 -51.88
11-14 13G/A Commodore Capital Lp 3.90 2.79
11-12 13G/A Fmr Llc 15.00 15.81
11-08 13G BlackRock, Inc. 5.20 0.00
10-23 13G Deutsch Peter E. 6.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-02-27 10-K re UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K
2024-11-18 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (Amendment No. 1)
2024-11-18 10-K/A re UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K/A (Amendment No. 2)
2024-11-18 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (Amendment No. 1)
2024-11-18 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (Amendment No. 1)
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-04 140,857 334,470 42.11
2025-06-03 130,556 372,231 35.07
2025-06-02 70,854 268,271 26.41
2025-05-30 71,024 239,194 29.69

(click for more detail)

Similar Companies
STTK – Shattuck Labs, Inc. SVRA – Savara Inc.
SWTX – SpringWorks Therapeutics, Inc. TARS – Tarsus Pharmaceuticals, Inc.
TECH – Bio-Techne Corporation


Financial data and stock pages provided by
Fintel.io